Predictors of recurrence following resection of intracranial chordomas

详细信息    查看全文

• 作者：Winward Choy^a ; Sergei Terterov^a ; Tania B. Kaprealian^b ; Andy Trang^a ; Nolan Ung^a ; Antonio DeSalles^a ; Lawrance K. Chung^a ; Neil Martin^a ; Michael Selch^b ; Marvin Bergsneider^a ; Harry V. Vinters^c ; William H. Yong^c ; Isaac Yang^a ; ^d ; ^{iyang@mednet.ucla.edu" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Chordoma ; Prognostic factors ; Radiation therapy ; Radiosurgery ; Surgery
• 刊名：Journal of Clinical Neuroscience
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：22
• 期：11
• 页码：1792-1796
• 全文大小：383 K

文摘

Management of intracranial chordomas remains challenging, despite improvements in microsurgical techniques and radiotherapy. Here, we analyzed the prognostic factors associated with improved rates of tumor control in patients with intracranial chordomas, who received either gross (GTR) or subtotal resections (STR). A retrospective review was performed to identify all patients who were undergoing resection of their intracranial chordomas at the Ronald Reagan University of California Los Angeles Medical Center from 1990 to 2011. In total, 57 patients undergoing 81 resections were included. There were 24 females and 33 males with a mean age of 44.6 years, and the mean tumor diameter was 3.36 cm. The extent of resection was not associated with recurrence. For all 81 operations, the 1 and 5 year progression free survival (PFS) was 87.5 and 40.4%, and 88.0 and 33.6% for STR and GTR, respectively (p = 0.90). Adjuvant radiotherapy was associated with improved rates of PFS (hazard ratio [HR] 0.20; p = 0.009). Additionally, age >45 years (HR 5.88; p = 0.01) and the presence of visual deficits (HR 7.59; p = 0.03) were associated with worse rates of tumor control. Tumor size, sex, tumor histology, and recurrent tumors were not predictors of recurrence. Younger age, lack of visual symptoms on presentation and adjuvant radiotherapy were associated with improved rates of tumor control following surgery. However, GTR and STR produced comparable rates of tumor control. The surgical management of intracranial chordomas should take a conservative approach, with the aim of maximal but safe cytoreductive resection with adjuvant radiation therapy, and a major focus on quality of life.